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Abstract
Background
By means of meta-analysis of information from all relevant epidemiologic studies, we exam-
ined the hypothesis that Schistosoma infection in school-aged children (SAC) is associated
with educational loss and cognitive deficits.
Methodology/Principal findings
This review was prospectively registered in the PROSPERO database (CRD4201604
0052). Medline, Biosis, and Web of Science were searched for studies published before
August 2016 that evaluated associations between Schistosoma infection and cognitive or
educational outcomes. Cognitive function was defined in four domains—learning, memory,
reaction time, and innate intelligence. Educational outcome measures were defined as
attendance and scholastic achievement. Risk of bias (ROB) was evaluated using the New-
castle-Ottawa quality assessment scale. Standardized mean differences (SMD) and 95%
confidence intervals (CI) were calculated to compare cognitive and educational measures
for Schistosoma infected /not dewormed vs. uninfected/dewormed children. Sensitivity anal-
yses by study design, ROB, and sequential exclusion of individual studies were imple-
mented. Thirty studies from 14 countries, including 38,992 SAC between 5–19 years old,
were identified. Compared to uninfected children and children dewormed with praziquantel,
the presence of Schistosoma infection and/or non-dewormed status was associated with
deficits in school attendance (SMD = -0.36, 95%CI: -0.60, -0.12), scholastic achievement
(SMD = -0.58, 95%CI: -0.96, -0.20), learning (SMD = -0.39, 95%CI: -0.70, -0.09) and mem-
ory (SMD = -0.28, 95%CI: -0.52, -0.04) tests. By contrast, Schistosoma-infected/non-
dewormed and uninfected/dewormed children were similar with respect to performance in
tests of reaction time (SMD = -0.06, 95%CI: -0.42, 0.30) and intelligence (SMD = -0.25, 95%
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CI: -0.57, 0.06). Schistosoma infection-associated deficits in educational measures were
robust among observational studies, but not among interventional studies. The significance
of infection-associated deficits in scholastic achievement was sensitive to ROB. Schisto-
soma infection-related deficits in learning and memory tests were invariant by ROB and
study design.
Conclusion/Significance
Schistosoma infection/non-treatment was significantly associated with educational, learn-
ing, and memory deficits in SAC. Early treatment of children in Schistosoma-endemic
regions could potentially mitigate these deficits.
Trial registration
ClinicalTrials.gov CRD42016040052
Author summary
Empirical evidence for cognitive or educational benefits of anti-Schistosoma treatment is
currently uncertain, despite the recommended practice of wide-scale deworming with
praziquantel. We addressed this knowledge gap by synthesizing information from 30 rele-
vant epidemiologic studies reporting on 38,992 children between 5–19 years old from 14
countries. In those studies, Schistosoma infection or non-dewormed status was associated
with educational loss and cognitive deficits. Specifically, there were small to moderate def-
icits in both school attendance and scholastic achievement. Similarly, Schistosoma infec-
tion or non-dewormed status was associated with deficits in learning and memory
domains of psychometrically tested cognitive function. However, there was no evidence
of Schistosoma infection- or non-deworming-associated deficits on tests of innate intelli-
gence or reaction-time. Overall, compared to Schistosoma-uninfected or to dewormed
children, the presence of Schistosoma infection or non-dewormed status was associated
with educational, learning, and memory deficits in school-aged children. The combined
evidence suggests that early treatment of children in Schistosoma-endemic regions could
mitigate these deficits.
Introduction
An estimated 800 million persons in tropical and sub-tropical countries are at risk of infection
by one of three main human Schistosoma parasites–S. mansoni, S. haematobium, and S. japoni-
cum [1]. As many as 240 million adults and children are actively infected [2–4] resulting in as
much as 3.3 million disability-adjusted life years (DALYs) lost per annum due to overt and
subclinical morbidities of Schistosoma infection [4, 5]. Sub-Saharan Africa is most affected;
children from endemic areas are often infected by two years of age and many remain chroni-
cally infected throughout their school-age years [6–8]. Periodic mass drug administration
(MDA) with praziquantel in school-aged children has been recommended for morbidity con-
trol by the World Health Organization [6]. However, Schistosoma-infected pre-school children
are not routinely treated in such settings, and they constitute a potentially high risk group for
accumulation of morbidity [9]. At present, there is no specific guidance for anti-Schistosoma
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drug treatment of preschool children, partly because of the lack of a child-friendly pediatric
formulation [10].
Treatment with praziquantel has a demonstrated effectiveness in reducing infection inten-
sity within individuals and in reducing the prevalence of infection within communities [11].
Such treatment results in clear-cut improvements with respect to advanced schistosomiasis-
associated morbidities such as urinary tract fibrosis and hepatosplenic disease, including peri-
portal fibrosis [12, 13]. Epidemiologic studies have associated Schistosoma infections with
adverse impacts on anemia, growth [14], fitness [15], pediatric quality-of-life [16], and sub-
optimal child development [17]. Definitively linking Schistosoma infections to these non-spe-
cific and sub-clinical morbidities is complicated in the context of poverty.[8, 12, 17, 18] How-
ever, plausible biologic mechanisms of these adverse impacts have been described [2, 19] and
the likely underestimation of their morbidity-related health impact has been highlighted [3].
In helminth-endemic regions, the recommendation of periodic deworming of children is
explained on the basis of its expected salutary impact on a range of child-health outcomes
including anemia [12], nutritional status [14, 17, 18, 20], and overall well-being [16]. In addi-
tion, periodic deworming has been linked directly or indirectly to enhancement of school
attendance and educational achievement among children enrolled in school [6, 14, 21, 22].
However, the empirical evidence-base for cognitive and educational benefits of deworming
remains controversial [23–27]. Recent criticism of the supposed benefits of deworming for
educational enhancement has emphasized the undue influence of a single study in evidence
reviews [28], which may have led to over-optimistic appraisals regarding the potential health
and poverty alleviation benefits of deworming programs [29, 30].
Recent reviews of MDA effects have, thus far, focused on the impact of soil-transmitted hel-
minth infections (STH), but health policy discussions–including those at the World Health
Organization [30, 31], have tended to generalize findings to all helminths. Because different
parasites can have dramatically different effects in terms of organ-specific and systemic pathol-
ogies, it is important now to distinguish the impact and potential benefits of individual anti-
helminthic therapies [32]. To date, the evidence base for cognitive or educational benefits of
anti-Schistosoma treatment has not undergone systematic review. The present systematic
review and meta-analysis addresses the following questions: a) among school-aged children
examined in the context of cross-sectional or case-control studies, is Schistosoma infection
associated with worse performance in neurocognitive tests or with educational loss? b) among
school-aged children enrolled in prospective studies with specific treatment for Schistosoma
infection, is lack of treatment with praziquantel associated with worse performance in neuro-
cognitive tests or with educational loss? For our current meta-analysis, we hypothesize that
non-treatment or infection with Schistosoma infection is associated with educational loss and
cognitive deficits in school-aged children from schistosomiasis-endemic regions.
Methods
Search strategy
This review, with pertinent information regarding our review protocol, was prospectively reg-
istered with the PROSPERO database as follows: http://www.crd.york.ac.uk/PROSPERO/
display_record.asp?ID=CRD42016040052 (see Supporting Information file S1 Text). We
searched Medline, Web of Science, and Biosis electronic databases for original research arti-
cles, conference abstracts, or dissertations available as of August 22, 2016. Databases were
searched with pre-specified keywords including “bilharzia”, “schistosomiasis”, “Schistosoma”,
“school attendance”, “attention”, “impairment”, “memory”, “cognition”, among others. The
complete search strategy is detailed in S2 Text.
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Population, inclusion and exclusion criteria, study design
This systematic review and meta-analysis is focused on school-aged children five years and
older. We did not restrict studies according to language, design, or publication date. Both
interventional and observational studies were included in this review if they evaluated cogni-
tive function in school-aged children using any psychometric test, or measured school atten-
dance or achievement in relation to infection by Schistosoma parasites of any species. We
excluded studies exclusively focused on pre-school aged children because of the absence of
educational measures and the use of neurocognitive tests (e.g., the Mullen test) that were diffi-
cult to classify in terms of neurocognitive domains. We excluded meta-analyses and primary
studies of soil-transmitted helminth infections where Schistosoma coinfection was absent.
Comparisons: Schistosoma infection vs. no infection & treatment with
praziquantel vs. placebo
Schistosoma infection status was determined by microscopic examination of stool or urine as
appropriate for species. Praziquantel was the primary deworming agent in interventional stud-
ies. The primary exposure for this meta-analysis included presence of infection or, operation-
ally, infection was categorically defined based on study design as follows: 1) untreated/placebo
versus praziquantel-treated in a randomized controlled trial, 2) any, versus no Schistosoma
infection in cross-sectional studies, or 3) pre-, versus post-praziquantel treatment, or infec-
tion-free versus persistent infection, among Schistosoma-infected individuals in a longitudinal
design study. “Untreated” refers to children determined to be infected but not dewormed.
Outcomes: Psychometrically assessed cognitive function
In the reviewed studies, psychometrically-assessed cognitive function was measured by a range
of instruments that, for the purposes of this meta-analysis, were categorized into four domains:
memory, learning/executive function, attention/reaction time, and intelligence (see S1 Table
for details). The memory domain instruments included tests of working (short-term) memory
as well as those of long-term memory. Attention/reaction time tests were those that measured
the ability of a child to sustain concentration on a particular object, action, or thought, includ-
ing their capacity to manage competing demands in their environments. The learning/execu-
tive function domain included tests to evaluate children’s performance in goal-oriented
behavior, particularly components that are important for scholastic advancement. These test a
cluster of cognitive processes that enable children to connect past experience with present
action, and by so doing, engage in planning, organizing, strategizing, paying of attention to
details, and to emotionally self-regulate, make necessary efforts to remember important details
required for attainment of future goals [29]. We included in the ‘intelligence’ domain psycho-
metric tests of intelligence quotient (IQ) that likely measures largely biologically-determined
cognitive abilities, in contrast to cognitive performance measures that are environmentally pli-
able [33].
It was common for studies to use a suite of psychometric instruments to assess a single or
multiple cognitive domains in enrolled children. When multiple instruments were used to
measure the same cognitive domain, a grand mean of scores and a grand mean of standard
deviation (SD) across all instruments were calculated. Thus, for each publication, one overall
mean and SD value was determined for each domain. A study could contribute data to differ-
ent cognitive domains if it used tools spanning across several cognitive domains. However,
each instrument only contributed to one single domain of function, as shown in S1 Table.
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Outcomes: Educational loss
Two dimensions of educational loss were tabulated–school attendance and scholastic achieve-
ment for children enrolled in school.
School attendance: For children enrolled in cross-sectional and longitudinal studies, atten-
dance rate was respectively defined as the number of days children attended school over the
past month or over the study period. In case-control studies, the percentage of children
enrolled vs. not enrolled in school was calculated for Schistosoma-infected and non-infected
children.
School achievement was assessed across studies based on: i) children’s pass rate on standard-
ized teacher-generated tests; ii) the percent of children who were in appropriate class for age;
iii) their enrollment in elite vs. non-elite schools; iv) their scores in the school function domain
of pediatric quality-of-life inventory; v) their change in class position after treatment for Schis-
tosoma infection; vi) an above average vs. average/below average scholastic performance as
rated by a teacher; or vii) their pass rate in any kind of educational test, whether teacher-
administered or not.
Study selection, data extraction and management
Two researchers (LM and AK) independently screened individual articles by title and abstract,
after which eighty-eight full text articles were assessed for eligibility for inclusion in this review.
Studies were excluded on the following basis: no outcome measure reported (n = 39), non-pri-
mary literature or a review article (n = 7), absence of both infection and outcome measures
(n = 6), no variation in exposure (n = 2), a limited meeting abstract duplicated by later full
publication (n = 3) and a nonhuman study (n = 1) Disagreements between reviewers on inclu-
sion of a given study were resolved by consensus between LM and AK. If no consensus was
reached, the article was further evaluated by an additional reviewer (AEE). Thereafter, two
researchers (AEE and NP) independently extracted relevant data for meta-analyses. Where dif-
ferences in approach to standard error (SE) estimation were noted, discrepancy was resolved
by consensus between AEE and NP. When a potentially relevant publication did not present
needed information for meta-analysis, the authors were contacted to request additional data. If
the dataset was publicly available, we obtained needed values directly [28].
Statistical analysis
The method for deriving SD from respective studies depended on how data were presented
in the original reports. Some papers presented median (m) and range (a to b) instead of
means and SD. These measures were converted into approximate mean and SD as follows:
x  aþ2mþb
4
; S2  1
12
ða  2mþbÞ2
4
þ ðb   aÞ2
 
, see [34], where x and S2 refer to the values of mean
and variance, respectively. Some studies reported mean of respective measures and 95% confi-
dence intervals. For such studies, SDs were derived as follows: SD = sqrt(N)(upper limit–lower
limit)/3.92. Other studies presented data on means and their standard errors (SE), and SD was
estimated as SD = SEthe square root of N, the study size. For studies presenting data on differ-
ences in mean scores between two time points for treated/infected vs. untreated/uninfected
groups, appropriate SD for mean difference was calculated using the approach recommended
by the Cochrane Collaboration [35].
For the meta-analysis, studies were grouped into six categories of outcomes used to measure
cognitive or school-based function: school attendance, school achievement, memory, learning,
IQ, or attention. Standardized mean difference (SMD) estimates and 95% confidence intervals
(CI) were calculated for each test. SMD estimates were classified as robustly statistically different
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if their confidence intervals excluded zero. SMD estimates were interpreted based on thresholds
described by Cohen [36], as follows: ‘trivial’ (< |0.20|), ‘small’ (| 0.20| to< |0.50|), ‘moderate’
( |50| to< |0.80|) or ‘large’ ( |0.80|) effects, according to standard practice in social science
research.
All analyses and plots were implemented in STATA, versions 11 or 12. Heterogeneity
between studies was measured with Higgins’s and Thompson’s I2 statistic and chi-square p-
values [37]. Where between-study heterogeneity was high, random effects modelling was used
to estimate a pooled summary effect across studies [38, 39]. In the absence of heterogeneity,
fixed effects modeling was performed [39]. Publication bias was assessed using the Egger test
[40]. In sensitivity analysis, we evaluated potential heterogeneity in pooled impact estimates
based on: i) observational vs. intervention study design; ii) the quality of original studies based
on the Newcastle-Ottawa quality assessment scale; and iii) by Schistosoma species. For sensitiv-
ity analyses by species, we distinguished between urogenital schistosomiasis (S. haematobium),
which is often obvious to affected children, and intestinal/hepatosplenic schistosomiasis (S.
mansoni/S. japonicum). The latter two infections are similarly diagnosed by stool exam and
infection is seldom obvious to most children. We examined the potential for overly influential
publications using the ‘metabias’ function in STATA to evaluate robustness of our pooled esti-
mate, based on sequential removal of individual publications from the calculation of summary
estimates. Lastly, we evaluated the impact of year of publication on the stability of the pooled
estimate by iteratively including studies based on year of publication–i.e. starting from the ear-
liest to the most recent publication using the ‘metacum’ function in STATA.
Quality assessment
Our investigation was guided by recommendations of the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses (PRISMA) initiative and the Meta-analysis of Observa-
tional Studies in Epidemiology (MOOSE) guidelines for observational studies [41]. Quality
ranking of each study was implemented using an adapted version of the Newcastle-Ottawa
quality assessment scale (NOQAS) [42, 43] to derive a quality score for each investigation with
respect to: i) representativeness of the infected population sample or the selection cases and
controls (this yielded a score with range 0 to 3); ii) comparability with respect to known cor-
relates of cognitive function/educational attainment (score range 0 to 6); iii) the absence of
bias in relation to outcome assessment in prospective cohort studies (0 to 3) or exposure
assessment in cross-sectional and case-control studies (0 to 3). We adapted the comparability
segment of this scale to account for confounding effects of age, sex, nutrition, and socioeco-
nomic status in the relation between Schistosoma infection and educational/cognitive out-
comes. Comparability with respect to these factors was either achieved by design (i.e. age or
sex restriction for observational studies, or randomization for RCTs), or analytically, via strati-
fied analyses or multivariable adjustment in regression models. Scores were assigned for
attainment of comparability with respect to these factors as follows: age (score = 1), sex
(score = 1), nutritional status (score = 2) and socioeconomic status (score = 2). For each
study, the initial raw quality score (max = 12) was rescaled to match the scale of 9 and then
classified as low, high, or very high risk of bias based on precedents in prior literature [42].
Results
Our database search yielded a total 2914 unique records. The screening of titles and abstracts
resulted in the exclusion of 2846 records leaving 78 unique papers for full text review. We iden-
tified an additional set of ten relevant studies from the bibliographies of relevant articles. Of
these 88 articles, 58 were excluded based on full text review for reasons pecified in Fig 1.
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A total of 30 epidemiologic studies that assessed differences in cognitive test scores (based
on psychometric tests) and/or educational status (measured as scholastic achievement or
school attendance rate) in relation to Schistosoma infection or treatment were selected for
inclusion (Table 1). Of these, 21 studies were cross-sectional [16, 44–56] or case-control [57–
63] design where children were classified based on presence vs. absence of Schistosoma infec-
tion. Seven were longitudinal studies or pre-post intervention studies that featured screening
and treatment for Schistosoma infections at the time of first assessment [28, 64–68]. In these
studies, outcome contrasts were made according to: a) the duration of persistent infection vs.
duration of an infection-free interval, and b) the number of children for whom intensity of
infection at last follow-up remained lower vs. the number of children for whom there was no
change from baseline infection status after treatment with praziquantel.
Two studies were randomized controlled studies. Only one included study was a classic
placbo-controlled randomized-trial intervention in which children with Schistosoma infection
Fig 1. Flow diagram for search and selection of included studies.
https://doi.org/10.1371/journal.pntd.0005524.g001
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Table 1. Characteristics of 30 eligible studies of educational or cognitive loss in relation to Schistosoma species infectiona.
Author Design Age
(years)
N for Infected,
Not Treated, or
Pre-treatment
N for
Uninfected,
Treated, or
Post-treatment
Outcome Domain
(s)
Evaluated by Schistosoma
Species
Involved
Country
Loveridge 1948 CC 11–18 91 108 Achievement Attendance of elite
vs. non-elite school
S. haematobium South Africa
Jordan 1962 Cohort 12–19 58 58 Achievement Class Rank
Improvement
S. haematobium Kenya
Goldin 1972 CS 9–12 112 80 Achievement Teacher ranking of
scholastic ability
S. haematobium Zambia
Bell 1973 Cohort 8–12 69 69 IQ Ravens Progressive
Matrix
S. haematobium
& S. mansoni
South Africa
Castle 1974 CS 11–18 26 308 Achievement,
Learning, Memory
Thurstone Mental
Abilities Test
S. haematobium South Africa
Epstein 1974 CS 13–14 26 to 43 132 to 224 Learning,
Achievement,
Attendance
Nelson Reading
Test, Class Rank,
Attendance Rate
S. mansoni St. Lucia
Ejezie 1981 CS 6–15 164 517 Achievement,
Attendance
% Passing in last
Year, % Attendance
S. haematobium Nigeria
Haycock 1983 CS 6–15 481 353 Achievement % in age-
appropriate class
S. haematobium South Africa
el-Hawy 1990 CS 13–17 300 300 Achievement,
Attendance
Pass rate,
Attendance
S. haematobium
S. mansoni
Egypt
Kimura 1992 Cohort 9–19 49 49 Attention Tanaka Binet
Intelligence Test
S. haematobium Kenya
Ekanem 1994 CS 5–15 177 285 Achievement,
Attendance
Teacher Given
Test, % attendance
S. haematobium Nigeria
Hussein 1996 CS 6–18 6471 (Upper)
11080 (Lower)
5149 (Upper),
3006 (Lower)
Enrollment rate % Attendance S. haematobium Egypt (Upper
& Lower
regions)
Fentiman 1997 CC 6–18 130 239 Attendance % enrolled in school S. haematobium Ghana
de Clerq 1998 CS 6–11 203 263 Attendance % Attendance S. haematobium Mali
Nazel 1999 CC 9–12 80 40 Memory, IQ,
Attendance,
Achievement
VF, WISC, %
Attendance,
Standardized Test
S. mansoni Egypt
Nokes 1999 RCT 5–16 89 92 Memory,
Attention
Fluency, FR, DSF,
CB, Picture Search
S. japonicum China
Useh 1999 CC 6–12 243 254 Attendance % enrolled in school S. haematobium Nigeria
Beasley 2000 CC 7–12 167 274 Attendance % Attendance S. haematobium Tanzania
Meremikwu 2000 Cohort 8–9 210 203 Achievement,
Attendance
Teacher
Administered Test,
% attendance
S. haematobium Nigeria
Tiruneh 2001 CC 6–15 597 518 Enrollment rate % Attendance S. mansoni Ethiopia
Jukes 2002 CS 9–15 241 97 Memory,
Learning,
Reaction Time,
Achievement
DS, WF, CB,
SWLT, Stroop,
CRT, PBT, SS,
Reading, Spelling,
Math
S. haematobium
+/- Hookworms
Tanzania
Miguel 2004 Cohort 6–18 92 Persistently
Infected
407 Uninfected
both years
Enrollment rate,
Achievement
% Attendance,
Change Scores
over 2 years
S. mansoni Kenya
Ezeamama 2005 CS 6–18 244 75 Memory,
Learning, IQ
VF/WRAML
Memory, WRAML
Learning, PNIT
S. japonicum The
Philippines
Mekheimar 2005 CC 6–12 57 42 Attendance % enrolled in school S. mansoni Egypt
(Continued)
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were randomized to praziquantel vs. placebo/no treatment [69]. The other study randomized
children to screening vs. non-screening for Schistosoma infections [70]. Children in the non-
screened arm remained untreated (although that sample was subsequently tested for infection
to distinguish infected from uninfected children). In that study, among children randomized
to screening, those found to be Schistosoma-infected were given treatment, and we were thus
able to derive differences in cognitive test scores between Schistosoma-infected/treated vs.
Schistosoma-infected/not-treated children (Table 2). The median follow-up duration across
the nine logitudinal studies was 12 months. Minimum follow-up duration was one month and
maximum follow-up duration was 36 months. In four of the longitudinal studies, follow-up
duration was 6 months or less. In another four studies, follow-up duration was more than 12
months. One study had a 12 month follow-up.
In all, a total of 38,992 children between the ages of 5 to 19 years from 14 countries in three
continents–Africa, Asia and North America, were included in this review. The vast majority of
studies were of children from Africa–Nigeria (n = 4), Egypt (n = 4), South Africa (n = 4), Tan-
zania (n = 3), Kenya (n = 4), Mali (n = 1), Coˆte D’Ivoire (n = 1), Zambia (n = 1); Ghana (n = 1)
and Ethiopia (n = 1). Three studies were conducted in Southeast Asia or Asia [The Philippines
(n = 2) and China (n = 1)], one study was conducted in St. Lucia (Caribbean), and another
study was implemented in Madagascar.
A total of 36,626 children were studied in the context of cross-sectional or case control stud-
ies. Of these, cognitive test scores and/or indicators of educational loss were measured in
23,126 (59.3%) children infected with one of three schistosomiasis species (S. haematobium
(20 studies), S. japonicum (3 studies), or S. mansoni (10 studies)). These infected children were
compared to 13,835 (40.6%) children without Schistosoma infection. A total of 2,366 children
were studied in the context of randomized intervention studies including praziquantel vs. pla-
cebo, or prospective treatment studies that included baseline and follow-up assessments of
Table 1. (Continued)
Author Design Age
(years)
N for Infected,
Not Treated, or
Pre-treatment
N for
Uninfected,
Treated, or
Post-treatment
Outcome Domain
(s)
Evaluated by Schistosoma
Species
Involved
Country
Grigorenko 2006 RCT 11–13 92 Screened
Not Treated
74 Screened &
Treated
Memory,
Learning,
Reaction Time,
Achievement
DS, WF, CB S. haematobium
+ hookworms
Tanzania,
Africa
Berhe 2009 CS 5–18 219 114 Attention % symptoms
leading to
distraction in class
S. mansoni Ethiopia
Ezeamama 2012 Cohort 6–18 214 Not Cured/
re-infected
39 Not re-
infected
Memory,
Learning, IQ
VF/WRAML
Memory, WRAML
Learning, PNIT
S. japonicum The
Philippines
Terer 2013 CS 5–18 352 450 Achievement Score in school
functioning
S. haematobium Kenya
Hurlimann 2014 Cohort 5–14 130 89 Memory,
Attention
Digit Span Test,
Code Transmission
Test
S. mansoni +
STH
Coˆte D’Ivoire
Rasoamanamihaja
2016
CS 7–10 684 1274 Enrollment rate % regular vs. non-
regular attendance
S. haematobium
+ S. mansoni
Madagascar
aAbbreviations: CC, Case-Control; CS, Cross-sectional; RCT, Randomized controlled trial; VF, verbal fluency; WRAML, wide range assessment of memory
and learning; PNIT, Philippine non-verbal intelligence test; DS, Digit Span; WF, word fluency; CB, Corsi Block; SWLT, Spanish word learning task; FR, Free
recall; DSF, Digit Span Forwards; CRT, choice reaction time; PBT, peg board task (dominant & non-dominant hand); SS = silly sentencies.
https://doi.org/10.1371/journal.pntd.0005524.t001
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cognitive function (Table 2). Of the 30 studies included in this review, three (10%) and 16
(53.3%) were judged to be at very high or high risk of bias, respectively, per the NOQAS
(Table 3).
Schistosoma infection and its associations with school attendance and
educational attainment
Sixteen studies evaluated Schistosoma infection-related differences in school attendance
(Table 2). Schistosoma infection-associated attendance deficits varied in magnitude and direc-
tion by study design. Specifically, we did not find any evidence of association between Schisto-
soma infection and school attendance among the two interventional studies (SMD = 0.03, 95%
CI: -0.73, 0.78; Table 4); however, the observed infection-associated deficit in school-atten-
dance was robust for the pooled estimate of 14 observational studies (SMD = -0.42, 95%CI:
-0.70, -0.14). Compared to uninfected or praziquantel-treated children, the magnitude and
direction of infection-associated deficit in school attendance was similar for children infected
with S. haematobium or S. mansoni. Within strata of study quality, the association between
infection and scholastic achievement was directionally consistent and statistically robust
(Table 4). Across all studies, regardless of design or ROB, a deficit in school-attendance was
evident for Schistosoma-infected or non-praziquantel-treated children compared to uninfected
or praziquantel treated children (n = 15 studies; SMD = -0.36, 95% CI: -0.60, -0.12).
The overall finding of schistosomiasis-associated achievement deficit (n = 16 studies; SMD =
-0.58, 95%CI: -0.96, -0.20) was directionally consistent but varied in magnitude by study design
and study quality (Tables 3 and 4). Specifically, achievement deficit with Schistosoma infection
was noted in the pooled estimate derived from four intervention studies, but the magnitude of
this association was lower and not statistically robust (SMD = -0.35, 95%CI: -0.71, 0.01; Table 4).
Compared to uninfected or PZQ-treated children, the infection or non-treatment associated def-
icit in scholastic attainment was directionally consistent across different Schistosoma species,
although the magnitude of effect was higher for infection with S. haematobium (SMD = -0.62;
95% CI:-1.09, -0.14) than for infection with S. mansoni (SMD = -0.22; 95% CI:-0.40, -0.05).
Table 2. Pooled estimates of Schistosoma infection/non-treatment effects on educational/cognitive loss–Evaluation of heterogeneity and publica-
tion bias.
Cognitive Domain # Studies SMD (95%CI)† Heterogeneity
test
Publication bias Studies Included
P-
valueφ
I2
(%)
P-valueα
Memory 8 -0.28 (-0.52, -0.04) 0.0001 78.6 0.786 [42, 48, 52, 58, 62, 67, 76]
Learning 6 -0.39 (-0.70, -0.09) 0.0001 79.4 0.793 [42, 47, 48, 52, 67, 76]
Intelligence Quotient Based
Assessments
4 -0.25 (-0.57, 0.06) 0.008 74.8 0.450 [48, 58, 76, 77]
Reaction Time 6 -0.06 (-0.42, 0.30) 0.030 88.5 0.142 [41, 52, 62, 64, 66, 67]
Educational Loss Assessments
Achievement 16 -0.58 (-0.96,
-0.20)
0.0001 97.9 0.595 [15, 25, 42–47, 49, 50, 52, 56, 58, 63, 65,
67]
School Attendance 16 -0.36 (-0.60,
-0.12)
<0.001 98.7 0.991 [15, 25, 43–47, 49–52, 54–60, 63, 65, 67]
† SMD < 0 suggests a negative effect of infection/non-treatment on the indicated outcome; SMD > 0 indicates a positive effect of infection on respective
outcomes.
φ: measures the extent to which there is heterogeneity across studies in terms of underlying results.
α: evaluates the tendency for increased publication of studies that show a statistically robust finding; here, a P < 0.05 suggests presence of publication bias.
https://doi.org/10.1371/journal.pntd.0005524.t002
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Table 3. Quality of evidence from individual studies included in the meta-analysisa.
Newcastle Ottawa Quality Assessment Scale
Study ID Design Description Selection
max = 3*
Comparability
max = 6*
Exposure
/Outcome
max = 3*
Scaled
Quality
Score
max = 9
Risk of
Bias
Grigorenko
2006
RCT Randomized 254 Tanzanian children 11–13 years old
to screening vs. no screening with 16 months of FU.
Screened, infected children were treated with ALB
+ PZQ. All randomized to no screening were untreated
but study distinguished "infected not treated" from
uninfected/untreated. Analyzed for association
between infected/untreated status, infected/treated vs.
uninfected/not treated status on cognitive function with
statistical control for multiple confounders.
*** ****** *** 9 Low
Ezeamama
2012
Cohort Treatment reinfection study of 253 schisto infected
Filipino children 6–18 years old followed for 18 months
with repeated assessment for infection and cognitive
function. Evaluated association between infection free
duration and performance in four cognitive tests.
Controlled for: age, sex, nutritional status,
socioeconomic status, coincident STH, and other
factors.
*** ****** *** 9 Low
Nazel 1999 CC 120 Egyptian children 9–12 years old. Infected cases
(mild & moderate/high intensity, n = 80) matched to
uninfected classmate controls (n = 40). Analyses
controlled for age. Data on socioeconomic status of
both parents, nutritional status, crowding index, and
number of siblings did not differ by infection category.
*** ****** ** 8 Low
Nokes 199967 RCT Placebo controlled 2x2 intervention trial among 181
Chinese children 5–16 years old with allocation to
treatment with: PZQ with ALB-placebo, ALB with PZQ-
placebo, PZQ and ALB, or PZQ-placebo and ALB-
placebo; FU duration = 3 months.
*** ****** ** 8 Low
Jukes2002 CS 338 Tanzanian children 9–15 years old. Included
uninfected, moderate, or heavy schistosome infection,
with or without coinfection with moderate intensity
hookworm. Multivariate control for multiple
confounders including SES, nutritional indices,
inflammation, and malaria coinfections.
*** ****** ** 8 Low
Miguel 2004 Cohort Prospective investigation of scholastic achievement
and attendance by infection status over 12 months in
499 Kenyan children 6–18 years old. Sample
restricted to those present at both FU periods. Robust
control for confounding covariates.
*** ****** ** 8 Low
Ezeamama
2005
CS 319 children 6–18 years Filipino children. Controlled
for age, sex, hemoglobin status, nutritional status,
socio-economic status, and coincident STH infections
*** ****** ** 8 Low
Berhe 2009 CS Included 333 Ethiopian children 5–18 years old.
Multivariable investigation of infection-related
differences in psychometric tests. Controlled
analytically for several confounders including SES,
nutritional status. The surrogate for attention "severe
cramps distracting class attentiveness" is inherently
subjective.
** ****** ** 8 Low
Terer 2013 CS Compared school functioning for schistosome-infected
and uninfected Kenyan children 5–18 years old.
Controlled for age, sex, nutritional, and socioeconomic
confounders via multivariable analyses.
*** ****** ** 8 Low
(Continued )
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Table 3. (Continued)
Newcastle Ottawa Quality Assessment Scale
Study ID Design Description Selection
max = 3*
Comparability
max = 6*
Exposure
/Outcome
max = 3*
Scaled
Quality
Score
max = 9
Risk of
Bias
Hurlimann 2014 Cohort 219 Ivorian children 5–14 years old. Repeated
treatment for schistosome and STH infection with 5
months follow-up. Controlled for age, sex,
socioeconomic, and nutritional status
*** ****** * 8 Low
Epstein 1974 CS Enrolled 267 St. Lucian children 13–14 years old.
Compared outcomes for children with infection and
uninfected. Age, sex, and SES adjusted for in
multivariable analysis.
*** **** ** 7 Low
Bell 1973 Cohort 138 South African Children 8–12 years old. Analyses
compared infected and uninfected children with
respect to change in IQ test over 12 months of repeat
testing. Authors state that each child was paired
(pairing factors unspecified) to eliminate variation due
to age, sex, grade, and school. Mostly descriptive
analyses reported.
*** *** ** 6 High
Fentiman 1997 CC Enrolled 352 Ghanaian children 6–18 years old.
Compared schistosome infection in enrolled and
unenrolled school aged children matched for age and
sex or class (if age-inappropriate for class). No
evidence of multivariable analysis but confounding by
age, sex, and to some extent SES, is addressed by
matching factors.
*** *** ** 6 High
Jordan 1962 Cohort Enrolled 116 boys 12–19 years old from hyper
endemic area around Lake Victoria. Treated with
Lucanthone hydrochloride or TwSb; untreated boys
served as controls. Scholastic ability was assessed at
enrollment and 6 months later. Boys in treatment
group improved their class position over six months
vs. those uninfected and/or infected but not treated.
*** * *** 5 High
Kimura 1992 Cohort Included 49 Kenyan children 9–19 years old confirmed
to be schisto infected. Allocated to PZQ or no
treatment without randomization. There was matching
by grade level and pre- vs. post-enrollment
assessment of cognition over 1 month. No difference
in groups by age, sex, infection intensity, or scores at
enrollment. Scores improved for treated but not for
untreated children. No evidence of control for sex,
SES, or nutritional status in multivariable analysis.
*** * ** 5 High
Ekanem 1994 CS 462 infected and uninfected Nigerian children 5–15
years old. Infected children were matched to
uninfected children by age and sex. No multivariable
analyses; no control for socioeconomic or nutritional
status.
*** ** ** 5 High
de Clerq 1998 CS Study of 466 infected & uninfected Malian children,
6–11 years old. Association age- and sex-adjusted in
multivariable analysis.
*** ** ** 5 High
Meremikwu
2000
Cohort 210 schistosome infected Nigerian children, all 8–9
years old, were treated with PZQ, followed for 36
months, and screened yearly for reinfection. Re-
infected children were retreated. Retention was high.
Did not control for sex, SES, or malnutrition.
*** * *** 5 High
(Continued )
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Table 3. (Continued)
Newcastle Ottawa Quality Assessment Scale
Study ID Design Description Selection
max = 3*
Comparability
max = 6*
Exposure
/Outcome
max = 3*
Scaled
Quality
Score
max = 9
Risk of
Bias
Rasoamana-
mihaja 2016
CS Enrolled 1958 children 7 to 10 years old from
Madagascar as part of a cluster randomized study
including 29 sentinel sites. 20 school attending and 4
non-school attending children from each cluster were
randomly selected analyzed for relationship of
infection (prevalence and intensity) to school
attendance. No difference between attendees vs. non-
attendees with respect to infection. However, non-
attendees had higher intensity of infection.
*** ** ** 5 High
Castle 1974 CS Included 334 South African children 11–18 years old
with or without subclinical schistosome infection.
Measured data on father occupation as SES
surrogate, behavioral risk factors, and pupil factual
knowledge of infection cause and prevention, but no
evidence of multivariable analysis.
*** ** 4 High
Ejezie 1981 CS Included 681 Nigerian children 6–15 years old.
Descriptive analyses of educational loss by infection
status. No evidence of adjustment for SES, age, sex,
or nutrition.
*** ** 4 High
el-Hawy 1990 CS Enrolled 600 Egyptian boys 13–17 years old.
Descriptive analysis of school performance by
schistosome infection status. No control for age, SES,
or nutritional status.
*** ** 4 High
Hussein 1996 CS Comparison of infection prevalence among enrolled
and unenrolled school children in upper Egypt
(n = 11,620) and lower Egypt (n = 14,806). Infection
prevalence and cultural practice with respect to
education of children differ by Northern vs. Southern
Egypt. All analyses region-stratified, hence we
maintain Upper and Lower Egypt as distinct regions
contributing unique data points in this meta-analysis.
Children were 6–18 years old.
*** ** 4 High
Useh 1999 CC Enrolled 560 Nigerian children 6–12 years old. School
attendance rate and non-enrollment rate were
determined based on head of household recall for
index child. Potential misclassification of enrollment
due to recall bias.
* ** ** 4 High
Beasley 2000 CC Enrolled 441 Tanzanian children 7–12 years old.
Comparison of enrollment rate in infected and
uninfected children. Mostly descriptive analysis
presented but information on SES, nutritional status
and other factors evaluated by infection status.
*** ** 4 High
Tiruneh 2001 CC Enrolled 1,115 Ethiopian children, 6–15 years old.
Comparison of schistosome infection prevalence
among enrolled and non-enrolled children. Descriptive
analysis with high potential for residual confounding by
SES, nutritional status, etc.
*** ** 4 High
Mekheimar
2005
CC Enrolled 99 Egyptian children 6–12 years old.
Comparison of enrollment rate by infection status via
descriptive analyses.
*** ** 4 High
Loveridge 1948 CC Included 199 South African children, 11–18 years old.
Descriptive comparison of enrollment in elite vs. non-
elite school by schistosome infection status.
** ** 3 Very
high
(Continued )
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Among observational study designs, scholastic achievement deficit was statistically robust and of
larger magnitude (n = 12 studies; SMD = -0.65, 95% CI: -1.12, -0.17, Table 4). Similarly, Schisto-
soma infection was not associated with deficits in scholastic achievement among studies identi-
fied as low risk of bias (n = 6 studies; SMD = -0.08, 95%CI: -0.21, 0.02; Table 4). The estimates of
infection-related deficit in scholastic achievement increased when study quality was lower: for
studies with high risk of bias (n = 7) the SMD = -0.84 (95% CI:-1.52, -0.16); for studies with very
high risk of bias (n = 7) SMD = -0.92 95% CI: -2.1, 0.28) although the estimated difference was
statistically imprecise (i.e., with a wider CI) among the studies with greatest risk of bias.
Impact of Schistosoma infection on psychometrically evaluated cognitive
domains
We found Schistosoma infection-associated deficits in memory tests (n = 8 studies; SMD =
-0.28, 95% CI: -0.52, -0.04; Table 2). Similarly, Schistosoma infection was associated with
small-to-moderate deficits in learning tests (n = 6 studies; SMD = -0.39, 95%CI: -0.70, -0.09;
Table 2). The Schistosoma infection-related deficits in memory tests were directionally consis-
tent by study design; although separate pooled estimates for interventional studies (n = 4 stud-
ies; SMD = -0.36, 95% CI: -0.61, 0.09) and observational studies (n = 4 studies; SMD = -0.15,
95% CI: -0.34, 0.03) were not statistically robust. For Schistosoma infection-related association
with learning, pooled estimates suggested the presence of deficits for infected/non-dewormed
vs. uninfected/praziquantel-treated children (n = 6 studies; SMD = -0.39, 95% CI: -0.70, -0.09).
However, the magnitude of this association differed according to study design. Here, larger
pooled standardized differences were realized for interventional studies (n = 2 studies; SMD =
-0.79, 95% CI:-1.19, -0.39) than for observational studies (n = 4 studies; SMD = -0.18, 95% CI:
-0.35, -0.01). Schistosoma infection was not significantly associated with performance on tests
of reaction time (n = 6 studies; SMD = -0.06, 95% CI: -0.42, 0.30) or performance in tests of
innate intelligence (n = 4 studies; SMD = -0.25, 95% CI: -0.57, 0.06). For all psychometrically-
assessed cognitive domains, the overall findings were not sensitive to study quality. Of note,
the majority of publications with psychometrically-evaluated endpoints had low risk of bias
and produced pooled estimates similar in magnitude and direction to the overall results
(Table 4).
Table 3. (Continued)
Newcastle Ottawa Quality Assessment Scale
Study ID Design Description Selection
max = 3*
Comparability
max = 6*
Exposure
/Outcome
max = 3*
Scaled
Quality
Score
max = 9
Risk of
Bias
Goldin 1972 CS Enrolled 192 Zambian children 9–12 years old.
Descriptive analysis of subjective teacher ranking of
index student as above or below average scholastic
achievement by schistosome infection status.
** ** 3 Very
high
Haycock 1983 CS 834 South African children 6–15 years old. Measured
whether students were at age appropriate classes or
not by schistosome infection status. No information on
confounders beyond age. No multivariable analysis.
** ** 3 Very
high
aAbbreviations: CC, Case-Control; CS, Cross-sectional; RCT, Randomized controlled trial; FU, Follow up; ALB, albendazole; PZQ, praziquantel; STH, soil-
transmitted helminths; SES, socioeconomic standing; TwSb, Stibophen
https://doi.org/10.1371/journal.pntd.0005524.t003
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Table 4. Pooled estimate of Schistosoma infection or non-treatment on educational and cognitive loss in school-aged children from schistosomi-
asis-endemic regions: Stratified by study design, Schistosoma species, and study qualitya,b.
Test of Association Test of Heterogeneity within stratum
STRATUM K SMD 95% CI PA PB I2 AM
Memory
Interventional Design 4 -0.36 [-0.81, 0.09] 0.12 <0.001 90 R
Observational Design 4 -0.17 [-0.33, 0.01] 0.058 0.61 61 F
S. haematobium 3 -0.45 [-1.07, 0.17] 0.15 <0.001 88 R
S. mansoni/japonicum 5 -0.19 [-0.41, 0.04] 0.10 0.02 65 R
Low ROB 7 -0.27 [-0.53, -0.004] <0.001 <0.001 81.5 R
All Studies Included 8 -0.28 [-0.52, -0.04] <0.001 <0.001 81 R
Learning
Interventional Design 2 -0.79 [-1.19, -0.39] <0.001 0.062 71 F
Observational Design 4 -0.18 [-0.34, -0.01] 0.04 0.576 0 F
S. haematobium 3 -0.46 [-1.15, 0.23] 0.19 <0.001 90 R
S. mansoni /japonicum 3 -0.36 [-0.54, -0.18] < 0.001 0.14 49 F
Low ROB 5 -0.41 [-0.75, -0.06] <0.001 <0.001 83 R
All Studies Included 6 -0.4 [-0.70, -0.09] 0.001 0.05 79 R
Reaction time
Interventional Design 4 0.13 [-0.03, 0.29] 0.12 0 58.2 F
Observational Design 2 -0.39 [-1.19, 0.40] 0.25 <0.001 84 R
S. haematobium 3 0.11 [-0.07, 0.29] 0.24 0.38 0 F
S. mansoni/ japonicum 3 -0.20 [-0.82, 0.42] 0.53 <0.00001 93 R
Low ROB 5 -0.07 [-0.49, 0.35] 0.26 <0.001 89 R
All Studies Included 6 -0.06 [-0.42, 0.30] 0.30 <0.001 88.5 R
Intelligence
All 4 -0.25 [-0.57, 0.06] 0.11 0.008 74 R
Low ROB 3 -0.29 [-0.73, 0.15] 0.19 0.003 84 R
Achievement
Interventional Design 4 -0.35 [-0.71, 0.01] 0.06 <0.001 85 R
Observational Design 12 -0.65 [-1.12, -0.17] <0.001 <0.001 98.3 R
S. haematobium 12 -0.62 [-1.09, -0.14] 0.01 < 0.001 98 R
S. mansoni 3 -0.22 [-0.40, -0.05] 0.01 0.32 11 F
Low ROB 6 -0.08 [-0.21, 0.02] 0.114 0.216 29 F
High ROB 7 -0.84 [-1.52, -0.16] <0.001 <0.001 95 R
Very High ROB 3 -0.92 [-2.1, 0.28] 0.185 <0.001 98.5 R
All Studies Included 16 -0.58 [-0.95, -0.20] <0.001 <0.001 98 R
Attendance
Interventional Design 2 0.03 [-0.73, 0.78] 0.277 <0.001 96 R
Observational Design 14 -0.36 [-0.64, -0.08] <0.001 <0.001 99 R
S. haematobium 10 -0.29 [-0.59, 0.01] 0.06 < 0.001 99 R
S. mansoni 4 -0.26 [-0.42, -0.01] 0.001 0.28 22 F
Low ROB 3 -0.24 [-0.42, -0.07] 0.006 0.286 20 F
High ROB 13 -0.34 [-0.63, -0.05] <0.001 <0.001 99 R
All Studies Included 16 -0.31 [-0.57, -0.05] <0.001 <0.001 98 R
aAbbreviations: K, number of studies; SMD, standard mean difference; CI, confidence interval; PA, P value for association; PB, P value for heterogeneity;
AM, analysis model: R, Random-effects; F, Fixed-effects; I2, measure of variability expressed in %
bValues in bold indicate significant associations. SMD < 0 suggests a negative effect of infection/non-treatment on the indicated outcome; SMD > 0
indicates a positive effect of infection on the respective outcome.
https://doi.org/10.1371/journal.pntd.0005524.t004
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Sensitivity analyses
High levels of heterogeneity were observed across included studies (P 0.03, I2 74.8%;
Tables 2 and 4) for all outcome measures, but there was no evidence of undue influence by
individual studies or of publication bias among the included studies (Egger’s test, all P-
value 0.142, Table 2). Overall, inferences based on pooled estimates were generally insensi-
tive to differences in study design (Table 4), to the exclusion of individual studies (S2 Table),
or to the influence of publication year (S1 Fig).
Discussion
Principal findings and interpretations
This systematic review and meta-analysis of the cognitive and educational impact of Schisto-
soma infection in school-aged children supports the hypothesis that infection is associated
with reduced school-attendance, with deficits in scholastic achievement and deficits in mem-
ory and learning domains of psychometrically evaluated cognitive function. It has previously
been conjectured that Schistosoma infection may affect school attendance, scholastic achieve-
ment, and cognitive function, either directly through via deposition of Schistosoma eggs within
the central nervous system, via physical discomfort and subsequent distraction due to the pres-
ence of the worms, or indirectly, via iron-deficiency and malnutrition [3, 71, 72]. However,
Schistosoma infection or non-treatment was not associated with performance in tests of innate
intelligence or reaction time. Inferences based on most pooled estimates for psychometrically
assessed endpoints were generally insensitive to study design, Schistosoma species, and risk of
study bias. However, associations between infection and educational outcomes were sensitive
to study design and study quality–especially estimates for impact on scholastic achievement.
The association between infection and scholastic achievement was directionally similar and
statistically robust regardless of Schistosoma species; however, average effects were substan-
tially larger for S. haematobium compared to S. mansoni infection. Cohen’s criteria for effect
size suggest that the average Schistosoma infection-related deficits in education, learning, and
memory performance range from ‘small’ to ‘moderate’. S. haematobium infection was associ-
ated with relatively larger deficits in scholastic achievement.
Prior meta-analysis of four randomized controlled trials that evaluated cognitive impacts of
STH infections–which sometimes co-occur with schistosomiasis, have reached a different con-
clusion about the cognitive and scholastic effects of STH infection and the impact of interval
treatments for STH [25, 26]. Those reviews concluded that there was substantial evidence that
deworming for soil-transmitted helminth infections does not yield a cognitive or educational
benefit. We note that our approach differed from these prior STH-based meta-analyses on sev-
eral grounds: a) we included both interventional and observational studies to take advantage
of all research data available on this question, b) we evaluated Schistosoma-associated impacts
on two domains of educational loss (attendance and achievement), c) we further defined
domains of cognitive function based on psychometrically-assessed testing to include the fol-
lowing: learning, memory, attention, and intelligence and d) the intervention, as defined in
this meta-analysis, denoted treatment for Schistosoma infection, whether or not the study was
randomized.
We intentionally included data from all available epidemiologic studies–whether interven-
tional or observational in design, in this first systematic review and meta-analysis of Schisto-
soma infection-related differences in cognitive and educational outcomes. The inclusion of all
available evidence reflects current standards for clinical evidence-gathering to inform health
policy, in order to shape clinical practice based on the ‘best available’ relevant information [23,
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24]. Future randomized-controlled trials to address this question are expected to be limited in
scope and may be considered ethically objectionable given the current widespread adoption of
deworming for schistosomiasis and STH. The current adoption of ‘preventive chemotherapy’
guidelines has been based on helminth-associated adverse effects on anemia and child growth.
In consequence, meta-analysis of available evidence, as performed in the present study,
remains the most practical strategy to inform current policy. By this approach, we have identi-
fied ‘small to moderate’ infection-related deficits in education, learning, and memory perfor-
mance using the Cohen’s criteria of effect size. However, such numerically small deficits (per
Cohen’s criteria) may significantly underestimate clinical significance of infection for child-
hood development, as Schistosoma infection is an exposure affecting millions of children in
endemic regions. Hence, small to moderate deficits at the individual level may amount to large
and important differences in disease burden at the population level [73, 74]. Our interpretation
of SMD estimates is ultimately grounded in the importance of summary measures for clarify-
ing existing knowledge gaps regarding the relationship of Schistosoma infections to respective
outcomes, and the expected benefit of systematically lowering infection-related deficits in the
millions of children at risk.
As a limitation of our approach, we acknowledge the possibility of residual confounding
and bias in the primary literature, given that majority of included studies were observational
or non-randomized intervention trials. Only two of the 30 included studies used an RCT
design, thus a sensitivity analysis based on RCT vs. non-RCT study design was not possible.
However, as part of sensitivity analysis we evaluated the potential for differences in pooled esti-
mates based on our expanded definition of intervention as including longitudinal studies that
included praziquantel treatment. Investigation of pooled estimate sensitivity by region of
study, the year of publication, and by risk of bias did not result in materially different statistical
inferences. Specific investigation of publication bias suggests that any possible greater likeli-
hood of publishing positive studies did not unduly influence observed findings. Our approach
of including both interventional and non-interventional studies is consistent with theoretical
and empirical evidence that meta-analyses based on observational studies generally produce
estimates of effect similar to those from meta-analyses based on randomized controlled trials,
and that a priori exclusion of observational studies in systematic reviews is inappropriate and
inconsistent with the evidence-based medical decision-making approach [75, 76]. In addition,
the often restrictive inclusion criteria and short follow-up duration in RCTs could easily result
in outcomes largely different from when the same interventions are applied to a general
population.
Despite the intuitive appeal of our cognitive domain based evaluation, we acknowledge the
critique that our classification of psychometric instruments by domain required some level of
subjectivity, especially for tools that capture performance across multiple domains. We explic-
itly identified the instruments used in each study and, based on literature description of the
major cognitive domain assessed by each tool, combined related tools into four separate
domains. Ultimately, each instrument was assigned to one cognitive domain only. We have
described the logic for our choices in the supplementary information (S1 Table) to provide a
basis for further discussion and give sufficient context for critical evaluation of our approach
in developing future studies.
Our decision to combine psychometric evaluations of cognitive functions in four domains
(based on the primary capacity being tested) is a strength of our empirical approach. By so
doing, we recognize that Schistosoma infection may not have equal impact on all cognitive
domains. For example, to the extent that innate intelligence is strongly influenced by fixed or
heritable factors, we did not anticipate infection related differences on tests of ‘intelligence
quotient’. Unlike intelligence tests, we considered the other tests of memory, learning, and
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reaction time to be more sensitive to infection, and thus modifiable by presence/non-treat-
ment vs. absence/treatment of Schistosoma infection. Unexpectedly, reaction time was not
associated with Schistosoma infections. However, our findings of infection-related reductions
in learning and memory tests are consistent with our hypotheses that these cognitive domains
are sensitive to adverse environmental perturbations–including Schistosoma infection.
Remaining gaps, and recommendations for future research
The finding of infection-related cognitive deficits and educational loss reported here is clini-
cally and health policy-relevant for mitigating the cognitive and functional morbidities of
Schistosoma spp. infection in children. The ‘small-to-moderate’ effects demonstrated may, in
reality, be an underestimate of the lifetime impact of Schistosoma infection on personal perfor-
mance (as affected via ultimately irreversible educational and cognitive losses). Typical epide-
miologic studies necessarily include only a constrained portion of the relevant etiologic period.
Among school-age children, Schistosoma infection is often effectively already chronic and/or
recurrent, with reinfection rates extremely high in the absence of meaningful environmental
interventions to reduce re-infection following treatment. The cumulative cognitive and educa-
tional impact of persistent infection may not be adequately captured by the relatively short-
term investigations of treatment impact included in this meta-analysis.
In schistosomiasis-endemic regions, many children are infected by age two and remain
chronically infected through school-age and late adolescence [9]. Under current national Schis-
tosoma control treatment guidelines, preschool-age children are not treated as part of routine
deworming programs for STH or schistosomiasis [1, 6, 30]. These children may therefore suf-
fer cumulative damage to their health and function that is currently not reflected in most
short-term study outcomes (or this meta-analysis). Of note, recent investigations have demon-
strated the safety and efficacy of praziquantel for treatment of Schistosoma infection in pre-
school children [9]. The existence of an adverse developmental impact of Schistosoma
infection on cognitive/educational domains would be a major justification for expanding the
age-bracket of children who should be treated with praziquantel. Currently, evidence suggests
that the timing of infection across a life path is especially consequential in terms of the severity
of cognitive and physiologic impairments experienced [77, 78]. Future investigations evaluat-
ing the relative differences in cognitive outcomes for pre-school children with and without
Schistosoma infection will be important for understanding the magnitude of potential impact
of better prevention of Schistosoma infection.
It is currently unknown whether the cognitive and educational loss associated with Schisto-
soma infection can be reversed with treatment alone. The fact that infection often occurs in the
context of malnutrition, coincident parasitic infections, and extreme poverty suggests that cog-
nitive remediation efforts will need to be multi-faceted, using an integrated disease manage-
ment framework. We expect that educational and cognitive interventions will be most
effective if initiated earlier in life and that the package of interventions may need to include
remedial instruction, the prevention of reinfection for treated/cured children, management of
comorbid health conditions, and interventions for improvement of nutritional status.
Policy implications
Our investigation suggests that Schistosoma infection/non-treatment is associated with educa-
tional and cognitive loss. Our findings further suggest a definite cognitive and educational
benefit of anti-schistosomal deworming among school-age children. Future complex interven-
tion studies of early childhood interventions, focused on improving child well-being and cog-
nitive potential, are needed to determine to what extent these observed deficits are preventable
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or reversible. Interventions that employ an integrated disease management framework will
likely identify cost-efficiencies for leveraging existing disease and nutrition treatment pro-
grams in helminth-affected regions.
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